Mumbai, Aug. 21 -- The inspection was conducted from 18th August 2025 to 20th August 2025 with none critical & major observations.

Innova Captab is an integrated pharmaceutical company in India with a presence across the pharmaceutical value chain, including research and development, manufacturing, drug distribution and marketing, and exports. The company has three businesses: CDMO (contract development and manufacturing organization) services and products, domestic branded generics, and international branded generics.

The company's consolidated net profit rose 5.2% to Rs 31.02 crore on 19.5% increase in net sales to Rs 351.54 crore in Q1 FY26 over Q1 FY25.

Published by HT Digital Content Services with permission from Capital Market....